United States Animal Health Market to Reach $35.83 Billion by 2033, Driven by Veterinary Care Expansion & Livestock Wellness

Leander, Texas and Tokyo, Japan - Dec.04.2025
As per DataM intelligence research report" The Global Animal Health Market size reached US$ 58.64 Billion with a rise of US$ 62.69 Billion in 2024 and is expected to reach US$ 119.44 Billion by 2033, growing at a CAGR of 7.5% during the forecast period 2025-2033." Livestock productivity needs and rising pet care spending are driving advancements in the global animal health industry.

Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/animal-health-market?Prasad

United States: Recent Industry Developments

✅ In January 2025, Zoetis launched the "Vetscan OptiCell," a revolutionary AI-powered hematology analyzer for veterinary clinics. The device uses cartridge-based technology to provide lab-quality blood counts in minutes at the point of care. It significantly improves diagnostic efficiency for U.S. veterinarians.

✅ In November 2025, Elanco Animal Health reported strong adoption of "Zenrelia," a novel JAK inhibitor for canine dermatology launched earlier in the year. The drug offers a new daily oral option for controlling itching and inflammation in dogs. It challenges existing therapies in the lucrative U.S. pet dermatology market.

✅ In September 2025, Merck Animal Health (MSD) presented new data on "Numelvi," a treatment for allergic dermatitis in dogs, at a major U.S. veterinary conference. The findings highlighted the drug's rapid onset of action and safety profile. It expands the therapeutic toolkit for U.S. vets treating chronic skin conditions.

✅ In August 2025, Boehringer Ingelheim received FDA approval for a new long-acting injectable specifically for managing diabetes in cats. The product reduces the burden of daily insulin injections for pet owners. It addresses a major compliance barrier in feline chronic care in the U.S.

Japan: Recent Industry Developments

✅ In November 2025, Zenoaq (Nippon Zenyaku Kogyo) announced the expansion of its startup subsidiary, Hundred, to focus on animal welfare and testing alternatives. The move aims to develop cruelty-free testing methods and ethical pet care solutions. It reflects a growing consciousness of animal welfare in Japan's corporate sector.

✅ In October 2025, MSD Animal Health Japan presented efficacy data for "Bovilis Nasalgen-C," an intranasal vaccine for calves. The vaccine protects against bovine coronavirus, a major cause of respiratory and enteric disease. It supports the productivity of Japan's Wagyu and dairy industries.

✅ In July 2025, a Japanese research team at Nippon Veterinary and Life Science University validated a new rapid test for tick-borne diseases in pets. The kit detects SFTS virus, which poses a zoonotic risk to owners. It enhances public health surveillance in Japan's pet population.

✅ In April 2025, DS Pharma Animal Health launched a digital health platform for monitoring post-operative recovery in dogs. The app connects owners with vets to track vital signs and wound healing remotely. It promotes the digitization of veterinary care in Japan.

Animal Health Market: Drivers
The animal health market is witnessing strong growth as demand rises for livestock productivity, companion animal care, and prevention of zoonotic diseases. Increasing pet adoption and humanization trends are driving veterinary services, diagnostics, nutritional supplements, and preventive treatments. Growth in global meat, dairy, and poultry production is boosting demand for vaccines, therapeutics, and biosecurity solutions. Technological advancements in genomics, precision livestock farming, and wearable monitoring devices are transforming animal management. Rising awareness of food safety and livestock welfare is accelerating market expansion.

Collaborations among pharmaceutical companies, veterinary clinics, and biotech innovators are improving access to advanced treatments. Regulatory support for antimicrobial stewardship and safe animal product production is shaping healthier market dynamics. Growth of online pet pharmacies and tele-veterinary platforms is expanding accessibility for pet owners. Increasing R&D in monoclonal antibodies, microbiome therapies, and digital health tools is enhancing treatment outcomes. With strong demand drivers across livestock and companion segments, the animal health market continues to scale rapidly.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/animal-health-market?Prasad

Animal Health Market: Major Players
Zoetis, Boehringer Ingelheim International GmbH, Elanco, Merck & Co., Ceva, Virbac, Vetoquinol, Dechra, Phibro Animal Health Corporation, and Bimeda US, among others.

Segment Covered in the Animal Health Market:
By Animal Type
Production animals lead with 55% share, driven by rising demand for meat, dairy, and poultry products, requiring enhanced healthcare and disease management solutions. Companion animals hold 45%, supported by growing pet adoption, increased spending on pet wellness, and rising awareness of preventive care. Both segments are seeing innovation in vaccines, nutraceuticals, and advanced therapeutics, ensuring improved animal health outcomes globally. Increasing regulatory focus on livestock health further boosts the production animal segment. Overall, the market growth is supported by both industrial and household animal care trends.

By Product Type
Biologics dominate with 28% share, fueled by increasing adoption of vaccines and immunotherapies for livestock and pets. Pharmaceuticals hold 25%, driven by rising prevalence of animal diseases and demand for therapeutic interventions. Feed additives account for 20%, supporting growth in nutrition, productivity, and immunity. Diagnostics represent 15%, powered by advanced testing kits and rapid disease detection tools. Supplements and other products contribute 12%, including nutraceuticals and functional additives enhancing animal wellness.

By Distribution Channel
Hospitals lead with 40% share, offering prescription-based treatments, veterinary care, and preventive services for both production and companion animals. E-commerce holds 25%, rapidly growing due to convenience, wider product availability, and rising digital adoption among pet owners and farmers. Retail stores account for 22%, including veterinary pharmacies and specialized pet care outlets. Other channels contribute 13%, encompassing feed mills, government distribution programs, and cooperative networks. The distribution mix reflects increasing access to animal health solutions globally.

Regional Analysis
North America
North America captures 32% share, driven by high pet ownership, advanced veterinary services, and strong adoption of biologics and pharmaceuticals. The U.S. leads with widespread veterinary infrastructure, preventive vaccination programs, and regulatory support. Canada contributes through livestock health initiatives and companion animal care. E-commerce penetration accelerates product availability. North America remains a major innovation hub for animal health solutions.

Europe
Europe holds 28% share, supported by stringent livestock health regulations, growing pet ownership, and advanced animal care services. Germany, France, and the UK lead in biologics adoption and veterinary innovation. The region sees rising investments in companion animal therapeutics and feed additives. E-commerce and retail channels expand product reach. EU initiatives promoting animal welfare and disease control further support market growth.

Asia Pacific
Asia Pacific captures 25% share, expanding due to rising meat and dairy demand, increasing pet adoption, and rapid urbanization. China, India, and Japan dominate production animal health, leveraging vaccines, feed additives, and therapeutics. Companion animal segment grows with urban pet owners and rising awareness. E-commerce adoption accelerates distribution. Government programs and veterinary infrastructure support market expansion.

South America
South America accounts for 10% share, driven by livestock-intensive economies like Brazil and Argentina. Production animal health dominates, supported by vaccines, pharmaceuticals, and feed additives. Companion animal segment grows slowly with increasing urbanization. Veterinary hospitals and retail channels expand availability. Regional initiatives for livestock disease management support market development.

Middle East & Africa
Middle East & Africa hold 5% share, led by GCC nations investing in livestock and companion animal care. Production animal segment dominates due to livestock farming and dairy demand. Companion animal adoption is rising gradually. Hospitals and retail channels expand access. Limited infrastructure is offset by growing government focus on animal health programs and imports of biologics and therapeutics.

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=animal-health-market
(Purchase 2 or more Repots and get 50% Discount)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?Prasad

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.